Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.
The FDA designated this a Class I Recall after 860 serious injuries and 7 deaths were reported related to falsely low glucose readings. Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and ...
The US Food and Drug Administration has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus continuous glucose monitors to Class I, the highest level of urgency. The recall, which ...
This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...
Health care technology company Abbott has recalled certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring systems because the sensors are displaying incorrect glucose ...
(AP Photo/Jacquelyn Martin, File) (Jacquelyn Martin, Copyright 2018 The Associated Press. All rights reserved.) A voluntary recall has been issued for certain glucose ...
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors. In December 2025, FDA posted an early alert that Abbott Diabetes Care was ...
Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...
Abbott Diabetes Care has advised that certain glucose monitor sensors be removed from use or sale after the FDA classified the action as its most serious type of recall. The recall involves specific ...
(FOX40.COM) — The most serious type of recall has been issued for two types of glucose sensors after seven deaths and hundreds of injuries associated with the defective devices. Abbott Diabetes Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results